CN116636613A - Formula food with full nutrition and special medical application as well as preparation method and application thereof - Google Patents
Formula food with full nutrition and special medical application as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN116636613A CN116636613A CN202310421131.6A CN202310421131A CN116636613A CN 116636613 A CN116636613 A CN 116636613A CN 202310421131 A CN202310421131 A CN 202310421131A CN 116636613 A CN116636613 A CN 116636613A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- powder
- special medical
- vegetable oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 29
- 230000035764 nutrition Effects 0.000 title claims abstract description 24
- 235000013305 food Nutrition 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 63
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 44
- 239000008158 vegetable oil Substances 0.000 claims abstract description 44
- 239000003094 microcapsule Substances 0.000 claims abstract description 38
- 239000000284 extract Substances 0.000 claims abstract description 31
- 235000015097 nutrients Nutrition 0.000 claims abstract description 25
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 20
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 18
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 16
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 16
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 16
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 16
- 229940088594 vitamin Drugs 0.000 claims abstract description 16
- 229930003231 vitamin Natural products 0.000 claims abstract description 16
- 235000013343 vitamin Nutrition 0.000 claims abstract description 16
- 239000011782 vitamin Substances 0.000 claims abstract description 16
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 15
- 235000010755 mineral Nutrition 0.000 claims abstract description 15
- 239000011707 mineral Substances 0.000 claims abstract description 15
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 12
- 240000004371 Panax ginseng Species 0.000 claims abstract description 12
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 12
- 235000008434 ginseng Nutrition 0.000 claims abstract description 12
- 229920001202 Inulin Polymers 0.000 claims abstract description 11
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 11
- 229940029339 inulin Drugs 0.000 claims abstract description 11
- 241000195493 Cryptophyta Species 0.000 claims abstract description 10
- 240000008042 Zea mays Species 0.000 claims abstract description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 10
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 10
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 10
- 235000005822 corn Nutrition 0.000 claims abstract description 10
- 235000021323 fish oil Nutrition 0.000 claims abstract description 10
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 10
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims abstract description 10
- 235000019198 oils Nutrition 0.000 claims abstract description 10
- 239000006188 syrup Substances 0.000 claims abstract description 10
- 235000020357 syrup Nutrition 0.000 claims abstract description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 52
- 150000001875 compounds Chemical class 0.000 claims description 24
- 238000002156 mixing Methods 0.000 claims description 21
- 229930003270 Vitamin B Natural products 0.000 claims description 19
- 235000019156 vitamin B Nutrition 0.000 claims description 19
- 239000011720 vitamin B Substances 0.000 claims description 19
- -1 vitamin compound Chemical class 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 15
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 15
- 235000018102 proteins Nutrition 0.000 claims description 15
- 238000005507 spraying Methods 0.000 claims description 15
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 14
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 14
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 12
- 239000011738 major mineral Substances 0.000 claims description 12
- 235000011963 major mineral Nutrition 0.000 claims description 12
- 239000011573 trace mineral Substances 0.000 claims description 12
- 235000013619 trace mineral Nutrition 0.000 claims description 12
- 102000011632 Caseins Human genes 0.000 claims description 11
- 108010076119 Caseins Proteins 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 239000000839 emulsion Substances 0.000 claims description 10
- 239000011780 sodium chloride Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 239000003995 emulsifying agent Substances 0.000 claims description 8
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 8
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 7
- 235000010216 calcium carbonate Nutrition 0.000 claims description 7
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 7
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 7
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 7
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 7
- 239000011706 ferric diphosphate Substances 0.000 claims description 7
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 7
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 7
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 7
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 7
- 239000001095 magnesium carbonate Substances 0.000 claims description 7
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 7
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 7
- 229940099596 manganese sulfate Drugs 0.000 claims description 7
- 239000011702 manganese sulphate Substances 0.000 claims description 7
- 235000007079 manganese sulphate Nutrition 0.000 claims description 7
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 7
- 239000001103 potassium chloride Substances 0.000 claims description 7
- 235000011164 potassium chloride Nutrition 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- 239000011781 sodium selenite Substances 0.000 claims description 7
- 235000015921 sodium selenite Nutrition 0.000 claims description 7
- 229960001471 sodium selenite Drugs 0.000 claims description 7
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 7
- 239000011746 zinc citrate Substances 0.000 claims description 7
- 235000006076 zinc citrate Nutrition 0.000 claims description 7
- 229940068475 zinc citrate Drugs 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 102000014171 Milk Proteins Human genes 0.000 claims description 6
- 108010011756 Milk Proteins Proteins 0.000 claims description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 6
- 102000007544 Whey Proteins Human genes 0.000 claims description 6
- 108010046377 Whey Proteins Proteins 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 235000001465 calcium Nutrition 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 6
- 235000021240 caseins Nutrition 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- 235000021239 milk protein Nutrition 0.000 claims description 6
- 235000001968 nicotinic acid Nutrition 0.000 claims description 6
- 229960003512 nicotinic acid Drugs 0.000 claims description 6
- 239000011664 nicotinic acid Substances 0.000 claims description 6
- 229940055726 pantothenic acid Drugs 0.000 claims description 6
- 235000019161 pantothenic acid Nutrition 0.000 claims description 6
- 239000011713 pantothenic acid Substances 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 235000019166 vitamin D Nutrition 0.000 claims description 6
- 239000011710 vitamin D Substances 0.000 claims description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 6
- 229940046008 vitamin d Drugs 0.000 claims description 6
- 235000021119 whey protein Nutrition 0.000 claims description 6
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- 235000000638 D-biotin Nutrition 0.000 claims description 5
- 239000011665 D-biotin Substances 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- 229930003448 Vitamin K Natural products 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 229960001231 choline Drugs 0.000 claims description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 229960000355 copper sulfate Drugs 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000004945 emulsification Methods 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 239000000469 ethanolic extract Substances 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 5
- 238000004537 pulping Methods 0.000 claims description 5
- 239000002002 slurry Substances 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 229940080237 sodium caseinate Drugs 0.000 claims description 5
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 229960003080 taurine Drugs 0.000 claims description 5
- 238000009489 vacuum treatment Methods 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 235000019168 vitamin K Nutrition 0.000 claims description 5
- 239000011712 vitamin K Substances 0.000 claims description 5
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- 229940046010 vitamin k Drugs 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 239000000126 substance Substances 0.000 abstract description 8
- 238000010521 absorption reaction Methods 0.000 abstract description 6
- 210000000936 intestine Anatomy 0.000 abstract description 6
- 239000012744 reinforcing agent Substances 0.000 abstract description 6
- 239000013589 supplement Substances 0.000 abstract description 6
- 230000001502 supplementing effect Effects 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract description 3
- 230000004206 stomach function Effects 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- 208000015380 nutritional deficiency disease Diseases 0.000 description 12
- 208000002720 Malnutrition Diseases 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 230000001071 malnutrition Effects 0.000 description 11
- 235000000824 malnutrition Nutrition 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 241000756943 Codonopsis Species 0.000 description 6
- 239000003623 enhancer Substances 0.000 description 6
- 108010074051 C-Reactive Protein Proteins 0.000 description 5
- 102100032752 C-reactive protein Human genes 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 230000006996 mental state Effects 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 229940071440 soy protein isolate Drugs 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 239000012675 alcoholic extract Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000007661 gastrointestinal function Effects 0.000 description 3
- 235000021388 linseed oil Nutrition 0.000 description 3
- 239000000944 linseed oil Substances 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 238000002137 ultrasound extraction Methods 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 235000004280 healthy diet Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000017971 listlessness Diseases 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229940111685 dibasic potassium phosphate Drugs 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000025301 tympanitis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pediatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The application discloses a formula food with full nutrition and special medical application, a preparation method and application thereof, and a nutrition supplementing reinforcing agent comprises maltodextrin, corn syrup, fructo-oligosaccharides, galacto-oligosaccharides, inulin, protein complex, vegetable oil microcapsule powder, DHA algae oil powder, arachidonic acid powder, fish oil microcapsule powder, vitamin complex and mineral complex. The vegetable oil microcapsule powder contains extracts of Korean ginseng, dangshen and coix seed, and the three substances act together to regulate intestines and stomach and improve intestines and stomach functions, so that the absorption of intestines and stomach to nutrient substances is promoted, and the absorption and utilization rate of the nutrition supplement reinforcing agent is improved. The total nutrient special medical use formula food contains various components, can provide sufficient nutrient substances, can supplement nutrition required by people of 1-10 years old, and is a total nutrient supplement with higher nutritional value.
Description
Technical Field
The application belongs to the technical field of nutritional preparations, and particularly relates to a nutritional supplement enhancer, a preparation method and application thereof.
Background
Malnutrition is a term describing health conditions and is caused by improper or inadequate diet, generally referred to as malnutrition resulting from insufficient intake, malabsorption or excessive loss of nutrients, but may also include overnutrition resulting from overeating or excessive intake of specific nutrients, and if a healthy diet consisting of an appropriate amount, type or quality of nutrients cannot be taken for a long period of time, the individual will be malnourished, and the long period of malnutrition may lead to starvation death, and the long period of malnutrition is the main cause of malnutrition, which is a major hazard to children:
1. in the early stage of malnutrition, the height has no influence, but as the illness state is aggravated, the bone growth is slowed down, the height is lower than normal, the mild malnutrition and the mental state are normal, but the severe state can be listlessness, poor response, low body temperature, thin and weak pulse, no appetite, diarrhea and constipation alternation, when the plasma albumin is obviously reduced, the blood albumin can be combined, the skin is shiny, the chronic ulcer can be formed by the collapse and infection in severe cases, and the severe malnutrition can have important viscera function damage, such as heart function reduction can be heart sound hypoplasia, blood pressure is low, pulse is slow, and the respiratory superficial is and the like;
2. because of the hypoimmunity of the children suffering from malnutrition, the children are susceptible to various infections such as recurrent respiratory tract infection, thrush, pneumonia, tuberculosis, tympanitis, urinary tract infection and the like; the diarrhea of the infant often persists without increasingly heavy malnutrition to form a vicious circle, the malnutrition can be accompanied by spontaneous hypoglycemia, the infant can suddenly appear as pale complexion, unclear mind, slow pulse, apnea, non-rising body temperature but no convulsion, if the infant is not diagnosed in time, death can be caused, and the 'homology of medicine and food' is one of the most valuable contributions to human beings in Chinese original medicine; traditional Chinese medicine emphasizes that "medical therapy is inferior to dietary therapy", and dietary therapy becomes the best choice for modern pursuing the return of uncut and true healthy diet; people can remove the pain in the process of enjoying food, avoid injection and medicine taking, and even the bitter of operation.
Currently, researchers have developed a number of nutritional supplement products that are specific to children. For example, the prior art discloses a children granule for enhancing immunity, which is prepared from whole milk powder, enzymolysis bone powder, lactoferrin, fructose, inulin, isomaltulose, egg yolk powder, instant coconut powder, colostrum basic protein, hydrolyzed egg yolk powder and compound nutrients; the prior art also discloses a compound vitamin tablet suitable for children under 10 years old, which comprises the following components: beta-carotene, vitamin C, vitamin D, vitamin B1, riboflavin, nicotinic acid, pantothenic acid, vitamin B6, biotin, folic acid, vitamin B12, calcium, iron, zinc and auxiliary materials.
As is clear from this, many nutritional supplements specific to children are available in the prior art, but the children have weak gastrointestinal functions, and cannot absorb the nutrients in the nutritional supplements effectively, so that the nutritional supplement effect of the nutritional supplements is not fully reflected.
Disclosure of Invention
Aiming at the prior art, the application provides a nutrition supplementing reinforcing agent to solve the problem that a consumer, especially children, can not thoroughly absorb the nutrition substances in the nutrition supplementing agent.
In order to achieve the aim, the technical scheme adopted by the application is to provide a formula food with full nutrition and special medical use, which comprises maltodextrin, corn syrup, fructo-oligosaccharides, galacto-oligosaccharides, inulin, protein complex, vegetable oil microcapsule powder, DHA algae oil powder, arachidonic acid powder, fish oil microcapsule powder, vitamin complex and mineral complex;
the vegetable oil microcapsule powder is prepared through the following steps:
s1: respectively carrying out alcohol extraction on Korean ginseng, dangshen and coix seed, then mixing the alcohol extracts of the Korean ginseng, the dangshen and the coix seed according to the mass ratio of 2-5:1-3:1-3, and then co-dissolving the mixture with maltodextrin, sodium caseinate, sodium tripolyphosphate and sucrose fatty acid ester according to the mass ratio of 3-5:10-15:15-20:1-3:1-2:0.5-2 in water to obtain emulsion;
s2: adding an emulsifying agent into the vegetable oil, and stirring for 10-20 min at room temperature at a rotating speed of 100-150 rpm to obtain emulsified vegetable oil;
s3: adding the emulsified vegetable oil into the emulsion under the stirring condition, and standing and emulsifying for 1-3 h at 50-60 ℃ after the addition;
s4: and (3) spray drying the feed liquid subjected to standing emulsification to obtain the vegetable oil microcapsule powder.
On the basis of the technical scheme, the application can be improved as follows.
Further, the nutrition supplementing and reinforcing agent comprises the following components in parts by mass:
25-100 parts of maltodextrin, 0-50 parts of corn syrup, 0-20 parts of fructo-oligosaccharide, 0-30 parts of galacto-oligosaccharide, 0-5 parts of inulin, 20-100 parts of protein compound, 10-80 parts of vegetable oil microcapsule powder, 0-10 parts of DHA algae oil powder, 0-10 parts of arachidonic acid powder, 0-20 parts of fish oil microcapsule powder, 0-10 parts of vitamin compound and 0-20 parts of mineral compound.
Further, the nutrition supplementing and reinforcing agent comprises the following components in parts by mass:
60 parts of maltodextrin, 25 parts of corn syrup, 5 parts of fructo-oligosaccharide, 13 parts of galacto-oligosaccharide, 1 part of inulin, 60 parts of protein compound, 45 parts of vegetable oil microcapsule powder, 5 parts of DHA algae oil powder, 5 parts of arachidonic acid powder, 10 parts of fish oil microcapsule powder, 5 parts of vitamin compound and 10 parts of mineral compound.
Further, the protein complex comprises the following components in parts by mass:
5-80 parts of whey protein, 5-25 parts of soybean protein isolate, 3-50 parts of casein and 5-15 parts of milk protein isolate.
Further, the protein complex comprises the following components in parts by mass:
40 parts of whey protein, 15 parts of soy protein isolate, 25 parts of casein and 10 parts of milk protein isolate.
Further, the vitamin complex comprises the following components in parts by mass:
5-10 parts of vitamin A, 3-6 parts of vitamin D, 2-5 parts of vitamin E, 4-8 parts of vitamin K, 1 5-10 parts of vitamin B, 2 1-5 parts of vitamin B, 6 3-7 parts of vitamin B, 2-6 parts of nicotinic acid, 3-5 parts of pantothenic acid, 1-4 parts of vitamin B, 2-4 parts of vitamin C, 2-5 parts of folic acid, 1-3 parts of choline, 0.5-2 parts of L-carnitine, 2-4 parts of D-biotin, 3-5 parts of taurine and 0.5-2 parts of potassium iodide.
Further, the mineral compound consists of trace minerals and macro minerals according to the mass ratio of 0.1-0.2:6-8; trace minerals include copper sulfate, ferric pyrophosphate, manganese sulfate, sodium selenite, and zinc citrate; macro minerals include dibasic calcium phosphate, calcium carbonate, magnesium carbonate, potassium chloride, dibasic potassium phosphate and sodium citrate.
Further, the mass ratio of the copper sulfate, the ferric pyrophosphate, the manganese sulfate, the sodium selenite and the zinc citrate in the trace mineral is 3-5:3-5:2-4:1-3:1-3; the mass ratio of the calcium hydrophosphate, the calcium carbonate, the magnesium carbonate, the potassium chloride, the dipotassium hydrogen phosphate and the sodium citrate in the macro mineral is 8-12:5-10:4-6:2-4:2-4:1-3.
Further, the alcohol extraction in S1 comprises the following steps:
s1: drying the extract until the water content is lower than 15%; then spraying 8-12% saline and 75% ethanol solution to the surface of the extract at 25-35 ℃, wherein each spraying is performed for 3-5 times when the surface of the extract is wet and the liquid drops do not fall, and the spraying interval time of the saline and the ethanol is 10-20 min;
s2: placing the extract to be extracted after the S1 treatment in a vacuum tank, vacuumizing, controlling the temperature in the tank to be 65-75 ℃, carrying out vacuum treatment for 2-4 hours, taking out, and cooling to room temperature;
s3: mixing the extract to be extracted after the S2 treatment with an ethanol solution with the volume concentration of 85-90% according to the feed liquid ratio of 1:10-20 g/mL, soaking for 2-4 h, and pulping to obtain pulp to be extracted;
s4: ultrasonic extracting the slurry to be extracted at 25-35 deg.c, and filtering to obtain the extractive solution;
s5: concentrating the extractive solution under reduced pressure until no ethanol smell is present, to obtain ethanol extract.
The application also discloses a preparation method of the total nutrient special medical use formula food, which comprises the following steps:
s1: weighing the components according to the mass ratio relation;
s2: mixing the weighed components uniformly to obtain the final product.
The application also discloses application of the total nutrient special medical purpose formula food in preparing children nutritional supplements.
The beneficial effects of the application are as follows:
1. the total nutrient special medical use formula food disclosed by the application contains various components, can provide sufficient nutrient substances, can supplement nutrition required by a user, and is an aldehyde nutrition supplement with higher nutritional value.
2. The vegetable oil microcapsule powder is added into the formula food with special medical application, and contains extracts of Korean ginseng, dangshen and coix seed, and the three substances act together to regulate intestines and stomach and improve intestines and stomach functions, so that the intestines and stomach can promote the absorption of nutrient substances and the absorption and utilization rate of nutrient supplement reinforcing agents.
Drawings
FIG. 1 is the effect of example and comparative example formulations on mouse serum CPR levels;
FIG. 2 is the effect of example and comparative formulations on mouse serum immunoglobulin IgA levels;
FIG. 3 is the effect of the example and comparative formulas on mouse serum immunoglobulin IgG levels.
Detailed Description
The following describes the present application in detail with reference to examples.
Example 1
A formula food with full nutrition and special medical application comprises the following components in parts by mass:
60 parts of maltodextrin, 25 parts of corn syrup, 5 parts of fructo-oligosaccharide, 13 parts of galacto-oligosaccharide, 1 part of inulin, 60 parts of protein compound, 45 parts of vegetable oil microcapsule powder, 5 parts of DHA algae oil powder, 5 parts of arachidonic acid powder, 10 parts of fish oil microcapsule powder, 5 parts of vitamin compound and 10 parts of mineral compound.
The protein compound comprises the following components in parts by mass:
40 parts of whey protein, 15 parts of soy protein isolate, 25 parts of casein and 10 parts of milk protein isolate.
The vitamin compound comprises the following components in parts by mass:
10 parts of vitamin A, 4 parts of vitamin D, 3 parts of vitamin E, 5 parts of vitamin K, 16 parts of vitamin B, 2 4 parts of vitamin B, 6 4 parts of vitamin B, 4 parts of nicotinic acid, 4 parts of pantothenic acid, 12 parts of vitamin B, 3 parts of vitamin C, 3 parts of folic acid, 2 parts of choline, 1 part of L-carnitine, 3 parts of D-biotin, 4 parts of taurine and 1 part of potassium iodide.
The mineral compound consists of trace minerals and macro minerals according to the mass ratio of 0.2:8; the trace mineral is prepared by mixing copper sulfate, ferric pyrophosphate, manganese sulfate, sodium selenite and zinc citrate according to the mass ratio of 4:4:3:2:2; the macro mineral is prepared by mixing calcium hydrophosphate, calcium carbonate, magnesium carbonate, potassium chloride, dipotassium hydrogen phosphate and sodium citrate according to the mass ratio of 10:8:5:3:3:2.
The vegetable oil microcapsule powder is prepared through the following steps:
s1: respectively carrying out alcohol extraction on Korean ginseng, radix codonopsis pilosulae and coix seed, wherein the alcohol extraction comprises the following steps:
(1) Drying the extract until the water content is lower than 15%; then spraying 10% saline and 75% ethanol solution to the surface of the extract at 30deg.C, wherein each spraying is performed for 4 times when the surface of the extract is wet and the liquid drops do not fall, and the spraying interval time of the saline and ethanol is 15min;
(2) Placing the extract to be extracted treated in the step (1) in a vacuum tank, vacuumizing, controlling the temperature in the tank to be 70 ℃, and taking out and cooling to room temperature after vacuum treatment for 3 hours;
(3) Mixing the extract to be extracted treated in the step (2) with an ethanol solution with the volume concentration of 90% according to the feed liquid ratio of 1:15g/mL, soaking for 3 hours, and pulping to obtain pulp of the extract to be extracted;
(4) Ultrasonic extracting the slurry to be extracted at 30 ℃, and filtering to obtain an extracting solution to be extracted; the ultrasonic frequency is 40KHz during ultrasonic extraction, and the ultrasonic time is 90min;
(5) Concentrating the extractive solution under reduced pressure until no ethanol smell is present, to obtain ethanol extract.
S2: mixing alcoholic extracts of Korean ginseng, radix codonopsis pilosulae and coix seed according to the mass ratio of 4:2:1, and then co-dissolving the mixture, maltodextrin, sodium caseinate, sodium tripolyphosphate and sucrose fatty acid ester according to the mass ratio of 4:12:16:2:1:1 in water to obtain emulsion;
s3: adding emulsifier (Tween-20) into vegetable oil (oleum Lini), stirring at 120rpm at room temperature for 15min to obtain emulsified vegetable oil; the added emulsifying agent accounts for 0.5% of the mass of the vegetable oil;
s4: adding the emulsified vegetable oil into the emulsion under the stirring condition, and standing and emulsifying for 2h at 55 ℃ after the addition is finished;
s4: and (3) spray drying the feed liquid subjected to standing emulsification to obtain the vegetable oil microcapsule powder.
The formula food with full nutrition and special medical application in the embodiment is prepared through the following steps:
s1: weighing the components according to the mass ratio relation;
s2: mixing the weighed components uniformly to obtain the final product.
Example 2
A formula food with full nutrition and special medical application comprises the following components in parts by mass:
25 parts of maltodextrin, 50 parts of corn syrup, 1 part of fructo-oligosaccharide, 30 parts of galacto-oligosaccharide, 1 part of inulin, 100 parts of protein compound, 10 parts of vegetable oil microcapsule powder, 10 parts of DHA algae oil powder, 1 part of arachidonic acid powder, 20 parts of fish oil microcapsule powder, 0.5 part of vitamin compound and 20 parts of mineral compound.
The protein compound comprises the following components in parts by mass:
5 parts of whey protein, 25 parts of soy protein isolate, 3 parts of casein and 15 parts of milk protein isolate.
The vitamin compound comprises the following components in parts by mass:
5 parts of vitamin A, 6 parts of vitamin D, 2 parts of vitamin E, 8 parts of vitamin K, 15 parts of vitamin B, 25 parts of vitamin B6 3 parts of vitamin B, 6 parts of nicotinic acid, 3 parts of pantothenic acid, 12 parts of vitamin B, 2 parts of vitamin C, 5 parts of folic acid, 1 part of choline, 2 parts of L-carnitine, 2 parts of D-biotin, 5 parts of taurine and 0.5 part of potassium iodide.
The mineral compound consists of trace minerals and macro minerals according to the mass ratio of 0.1:6; the trace mineral is prepared by mixing copper sulfate, ferric pyrophosphate, manganese sulfate, sodium selenite and zinc citrate according to the mass ratio of 3:5:2:3:1; the macro mineral is prepared by mixing calcium hydrophosphate, calcium carbonate, magnesium carbonate, potassium chloride, dipotassium hydrogen phosphate and sodium citrate according to the mass ratio of 8:10:4:4:2:3.
The vegetable oil microcapsule powder is prepared through the following steps:
s1: respectively carrying out alcohol extraction on Korean ginseng, radix codonopsis pilosulae and coix seed, wherein the alcohol extraction comprises the following steps:
(1) Drying the extract until the water content is lower than 15%; then spraying saline with the mass concentration of 12% and ethanol solution with the volume concentration of 75% on the surface of the to-be-extracted at the temperature of 25 ℃, wherein each spraying is performed for 5 times when the surface of the to-be-extracted is wet and the liquid drops do not fall, and the spraying interval time of the saline and the ethanol is 10min;
(2) Placing the extract to be extracted treated in the step (1) in a vacuum tank, vacuumizing, controlling the temperature in the tank to be 65 ℃, and taking out and cooling to room temperature after vacuum treatment for 4 hours;
(3) Mixing the extract to be extracted treated in the step (2) with an ethanol solution with the volume concentration of 85% according to the feed liquid ratio of 1:20g/mL, soaking for 4 hours, and pulping to obtain pulp of the extract to be extracted;
(4) Ultrasonic extracting the slurry to be extracted at 25 ℃, and filtering to obtain an extracting solution to be extracted; the ultrasonic frequency is 40KHz during ultrasonic extraction, and the ultrasonic time is 90min;
(5) Concentrating the extractive solution under reduced pressure until no ethanol smell is present, to obtain ethanol extract.
S2: mixing alcoholic extracts of Korean ginseng, radix codonopsis pilosulae and coix seed according to the mass ratio of 2:3:1, and then co-dissolving the mixture, maltodextrin, sodium caseinate, sodium tripolyphosphate and sucrose fatty acid ester according to the mass ratio of 3:15:15:3:1:2 in water to obtain emulsion;
s3: adding emulsifier (Tween-20) into vegetable oil (soybean oil), and stirring at 150rpm at room temperature for 10min to obtain emulsified vegetable oil; the added emulsifying agent accounts for 1% of the mass of the vegetable oil;
s4: adding the emulsified vegetable oil into the emulsion under the stirring condition, and standing and emulsifying for 1h at 60 ℃ after the addition;
s4: and (3) spray drying the feed liquid subjected to standing emulsification to obtain the vegetable oil microcapsule powder.
The formula food with full nutrition and special medical application in the embodiment is prepared through the following steps:
s1: weighing the components according to the mass ratio relation;
s2: mixing the weighed components uniformly to obtain the final product.
Example 3
A formula food with full nutrition and special medical application comprises the following components in parts by mass:
100 parts of maltodextrin, 5 parts of corn syrup, 20 parts of fructo-oligosaccharide, 0.5 part of galacto-oligosaccharide, 5 parts of inulin, 20 parts of protein compound, 80 parts of vegetable oil microcapsule powder, 0.5 part of DHA algae oil powder, 10 parts of arachidonic acid powder, 1 part of fish oil microcapsule powder, 10 parts of vitamin compound and 1 part of mineral compound.
The protein compound comprises the following components in parts by mass:
80 parts of whey protein, 5 parts of soy protein isolate, 50 parts of casein and 5 parts of milk protein isolate.
The vitamin compound comprises the following components in parts by mass:
10 parts of vitamin A, 3 parts of vitamin D, 5 parts of vitamin E, 4 parts of vitamin K, 110 parts of vitamin B, 2 1 parts of vitamin B, 67 parts of vitamin B, 2 parts of nicotinic acid, 5 parts of pantothenic acid, 12 parts of vitamin B, 4 parts of vitamin C, 2 parts of folic acid, 3 parts of choline, 0.5 part of L-carnitine, 4 parts of D-biotin, 3 parts of taurine and 2 parts of potassium iodide.
The mineral compound consists of trace minerals and macro minerals according to the mass ratio of 0.2:6; the trace mineral is prepared by mixing copper sulfate, ferric pyrophosphate, manganese sulfate, sodium selenite and zinc citrate according to the mass ratio of 5:3:4:1:3; the macro mineral is prepared by mixing calcium hydrophosphate, calcium carbonate, magnesium carbonate, potassium chloride, dipotassium hydrogen phosphate and sodium citrate according to the mass ratio of 12:5:6:2:4:1.
The vegetable oil microcapsule powder is prepared through the following steps:
s1: respectively carrying out alcohol extraction on Korean ginseng, radix codonopsis pilosulae and coix seed, wherein the alcohol extraction comprises the following steps:
(1) Drying the extract until the water content is lower than 15%; then spraying 8% saline and 75% ethanol solution to the surface of the extract at 35 ℃ until the surface of the extract is wet and the liquid drops do not fall, wherein the spraying of the saline and the ethanol is carried out for 3 times, and the spraying interval time of the two solutions is 20min;
(2) Placing the extract to be extracted treated in the step (1) in a vacuum tank, vacuumizing, controlling the temperature in the tank to be 75 ℃, and taking out and cooling to room temperature after vacuum treatment for 2 hours;
(3) Mixing the extract to be extracted treated in the step (2) with an ethanol solution with the volume concentration of 85% according to the feed liquid ratio of 1:10g/mL, soaking for 2 hours, and pulping to obtain pulp of the extract to be extracted;
(4) Ultrasonic extracting the slurry to be extracted at 35 ℃, and filtering to obtain an extracting solution to be extracted; the ultrasonic frequency is 40KHz during ultrasonic extraction, and the ultrasonic time is 90min;
(5) Concentrating the extractive solution under reduced pressure until no ethanol smell is present, to obtain ethanol extract.
S2: mixing alcoholic extracts of Korean ginseng, radix codonopsis pilosulae and coix seed according to a mass ratio of 5:1:3, and then co-dissolving the mixture, maltodextrin, sodium caseinate, sodium tripolyphosphate and sucrose fatty acid ester according to a mass ratio of 5:10:20:1:2:0.5 in water to obtain emulsion;
s3: adding emulsifier (Tween-20) into vegetable oil (soybean oil), stirring at 120rpm at room temperature for 20min to obtain emulsified vegetable oil; the added emulsifying agent accounts for 0.5% of the mass of the vegetable oil;
s4: adding the emulsified vegetable oil into the emulsion under the stirring condition, and standing and emulsifying for 3 hours at 50 ℃ after the addition is finished;
s4: and (3) spray drying the feed liquid subjected to standing emulsification to obtain the vegetable oil microcapsule powder.
The formula food with full nutrition and special medical application in the embodiment is prepared through the following steps:
s1: weighing the components according to the mass ratio relation;
s2: mixing the weighed components uniformly to obtain the final product.
Comparative example 1
The procedure of example 1 was repeated except that the vegetable oil microcapsule powder of example 1 was replaced with linseed oil microcapsule powder (purchased from doctor biotechnology Co., miss.).
Comparative example 2
The vegetable oil microcapsule powder in example 1 was replaced with linseed oil, and the rest was the same as in example 1.
Comparative example 3
The vegetable oil microcapsule powder in example 1 was removed, and the rest was the same as in example 1.
Experimental example
1. Construction of gastrointestinal absorption dysfunction mouse model
A mouse animal model with dysfunction of gastrointestinal absorption was constructed according to the method described in patent 201410853675.0 to examine whether the nutrition in the nutrition supplement enhancer of the present application was sufficiently absorbed.
2. Mouse feeding
70 mice (listlessness, emaciation, matt and yellow hair and pale tail) were selected and evenly divided into 7 groups, numbered 1-7. The mice numbered 1 to 6 were fed with the nutrient supplement prepared in examples and comparative examples once at 10 am and 3 pm, respectively, and the mice numbered 7 were fed with maltodextrin, in addition to the normal feed per day. Mice were continuously fed for 30 days and observed for changes in hair color, tail of paw, and body weight.
3. Analysis of results
1. The feeding results of the mice are shown in table 1.
TABLE 1 mouse feeding status
As can be seen from Table 1, the mice were given sufficient nutritional supplements and had a large change in both mental state and physical state as the feed was fed with the nutritional supplement enhancer of the present application.
Comparative example 1 in comparison with example 1, the vegetable oil microcapsule powder was replaced with linseed oil microcapsule powder, and although the nutritional supplement also included various nutrients, it was possible to supplement the nutrition to mice, but these nutrients were not absorbed sufficiently for mice with weak gastrointestinal functions, and thus, the mental state and physical state of the mice were improved but not restored to normal state.
Also, the nutritional ingredients in the nutritional agents of comparative examples 2 and 3 were not sufficiently absorbed by the mice having weak gastrointestinal functions, and the mice were not restored to normal state although the mental state and physical state were improved.
The mice numbered 7 were not supplemented with nutrient substances and did not undergo a fundamental change in status.
2. Examination of the effects of the formulations of the examples and comparative examples on the immune response and resistance of mice
After the end of feeding, the inner canthus was bled to detect the serum C-reactive protein (CPR) and serum immunoglobulin IgA, igG levels, and the results are shown in fig. 1-3, wherein fig. 1 shows the effect of the nutritional supplement enhancer on the serum CPR level of mice, fig. 2 shows the effect of the nutritional supplement enhancer on the serum immunoglobulin IgA level of mice, fig. 3 shows the effect of the nutritional supplement enhancer on the IgG level of mice, P < 0.05 compared with the control group, and # shows P < 0.05 compared with the comparative example 3.
As can be seen from fig. 1, the nutritional supplement fortifier of examples 1-3 can significantly reduce CPR levels in mice and reduce inflammatory responses in mice. As can be seen from fig. 2 and 3, examples 1 to 3 can significantly increase serum immunoglobulin IgA and IgG levels, enhancing mouse resistance.
While specific embodiments of the application have been described in detail in connection with the examples, it should not be construed as limiting the scope of protection of the patent. Various modifications and variations which may be made by those skilled in the art without the creative effort are within the scope of the patent described in the claims.
Claims (10)
1. A formula food with full nutrition and special medical application is characterized by comprising maltodextrin, corn syrup, fructo-oligosaccharide, galacto-oligosaccharide, inulin, protein compound, vegetable oil microcapsule powder, DHA algae oil powder, arachidonic acid powder, fish oil microcapsule powder, vitamin compound and mineral compound;
the vegetable oil microcapsule powder is prepared through the following steps:
s1: respectively carrying out alcohol extraction on Korean ginseng, dangshen and coix seed, then mixing the alcohol extracts of the Korean ginseng, the dangshen and the coix seed according to the mass ratio of 2-5:1-3:1-3, and then co-dissolving the mixture with maltodextrin, sodium caseinate, sodium tripolyphosphate and sucrose fatty acid ester according to the mass ratio of 3-5:10-15:15-20:1-3:1-2:0.5-2 in water to obtain emulsion;
s2: adding an emulsifying agent into the vegetable oil, and stirring for 10-20 min at room temperature at a rotating speed of 100-150 rpm to obtain emulsified vegetable oil;
s3: adding the emulsified vegetable oil into the emulsion under the stirring condition, and standing and emulsifying for 1-3 h at 50-60 ℃ after the addition;
s4: and (3) spray drying the feed liquid subjected to standing emulsification to obtain the vegetable oil microcapsule powder.
2. The total nutrient special medical use formula of claim 1, comprising the following components in parts by mass:
25-100 parts of maltodextrin, 0-50 parts of corn syrup, 0-20 parts of fructo-oligosaccharide, 0-30 parts of galacto-oligosaccharide, 0-5 parts of inulin, 20-100 parts of protein compound, 10-80 parts of vegetable oil microcapsule powder, 0-10 parts of DHA algae oil powder, 0-10 parts of arachidonic acid powder, 0-20 parts of fish oil microcapsule powder, 0-10 parts of vitamin compound and 0-20 parts of mineral compound.
3. The total nutrient special medical use formula of claim 2, comprising the following components in parts by mass:
60 parts of maltodextrin, 25 parts of corn syrup, 5 parts of fructo-oligosaccharide, 13 parts of galacto-oligosaccharide, 1 part of inulin, 60 parts of protein compound, 45 parts of vegetable oil microcapsule powder, 5 parts of DHA algae oil powder, 5 parts of arachidonic acid powder, 10 parts of fish oil microcapsule powder, 5 parts of vitamin compound and 10 parts of mineral compound.
4. A total nutrient special medical use formula as claimed in any one of claims 1 to 3, wherein the protein complex comprises the following components in parts by mass:
5-80 parts of whey protein, 5-25 parts of soybean protein isolate, 3-50 parts of casein and 5-15 parts of milk protein isolate.
5. A total nutrient special medical use formula as claimed in any one of claims 1 to 3, wherein the vitamin complex comprises the following components in parts by mass:
5-10 parts of vitamin A, 3-6 parts of vitamin D, 2-5 parts of vitamin E, 4-8 parts of vitamin K, 1 5-10 parts of vitamin B, 2 1-5 parts of vitamin B, 6 3-7 parts of vitamin B, 2-6 parts of nicotinic acid, 3-5 parts of pantothenic acid, 1-4 parts of vitamin B, 2-4 parts of vitamin C, 2-5 parts of folic acid, 1-3 parts of choline, 0.5-2 parts of L-carnitine, 2-4 parts of D-biotin, 3-5 parts of taurine and 0.5-2 parts of potassium iodide.
6. A total nutrient special medical use formula as claimed in any one of claims 1 to 3, wherein the mineral complex consists of trace minerals and macro minerals in a mass ratio of 0.1 to 0.2:6 to 8; the trace minerals comprise copper sulfate, ferric pyrophosphate, manganese sulfate, sodium selenite and zinc citrate; the macro minerals include calcium hydrogen phosphate, calcium carbonate, magnesium carbonate, potassium chloride, dipotassium hydrogen phosphate and sodium citrate.
7. The total nutrient special medical use formula of claim 6, wherein: the mass ratio of the copper sulfate, the ferric pyrophosphate, the manganese sulfate, the sodium selenite and the zinc citrate in the trace mineral is 3-5:3-5:2-4:1-3:1-3; the mass ratio of the calcium hydrophosphate, the calcium carbonate, the magnesium carbonate, the potassium chloride, the dipotassium hydrogen phosphate and the sodium citrate in the macro mineral is 8-12:5-10:4-6:2-4:2-4:1-3.
8. The total nutrient special medical use formula of claim 1, wherein the alcohol extract in S1 comprises the steps of:
s1: drying the extract until the water content is lower than 15%; then spraying 8-12% saline and 75% ethanol solution to the surface of the extract at 25-35 ℃, wherein each spraying is performed for 3-5 times when the surface of the extract is wet and the liquid drops do not fall, and the spraying interval time of the saline and the ethanol is 10-20 min;
s2: placing the extract to be extracted after the S1 treatment in a vacuum tank, vacuumizing, controlling the temperature in the tank to be 65-75 ℃, carrying out vacuum treatment for 2-4 hours, taking out, and cooling to room temperature;
s3: mixing the extract to be extracted after the S2 treatment with an ethanol solution with the volume concentration of 85-90% according to the feed liquid ratio of 1:10-20 g/mL, soaking for 2-4 h, and pulping to obtain pulp to be extracted;
s4: ultrasonic extracting the slurry to be extracted at 25-35 deg.c, and filtering to obtain the extractive solution;
s5: concentrating the extractive solution under reduced pressure until no ethanol smell is present, to obtain ethanol extract.
9. A method of preparing a total nutrient special medical use formula as claimed in any one of claims 1 to 8 comprising the steps of:
s1: weighing the components according to the mass ratio relation;
s2: mixing the weighed components uniformly to obtain the final product.
10. Use of the total nutrient special medical use formula of any one of claims 1 to 8 in the preparation of a nutritional supplement for children.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310421131.6A CN116636613A (en) | 2023-04-18 | 2023-04-18 | Formula food with full nutrition and special medical application as well as preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310421131.6A CN116636613A (en) | 2023-04-18 | 2023-04-18 | Formula food with full nutrition and special medical application as well as preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116636613A true CN116636613A (en) | 2023-08-25 |
Family
ID=87614308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310421131.6A Pending CN116636613A (en) | 2023-04-18 | 2023-04-18 | Formula food with full nutrition and special medical application as well as preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116636613A (en) |
-
2023
- 2023-04-18 CN CN202310421131.6A patent/CN116636613A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106616615A (en) | Clinical nutrient formula special for tumor and preparation method of clinical nutrient formula | |
| CN106962912A (en) | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof | |
| CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
| Fantuz et al. | Macro-and micronutrients in non-cow milk and products and their impact on human health | |
| CN107319524A (en) | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof | |
| CN106858595A (en) | One kind burn tailored version clinical nutrition formula and preparation method thereof | |
| CN106923207B (en) | Beef ball and preparation method thereof | |
| CN104783185B (en) | It is a kind of that there is strengthen immunity, health food of function of physical fatigue alleviation and preparation method thereof | |
| KR101896024B1 (en) | Functional food compositions comprising extracts of Garcinia Cambogia as active ingredients and method for preparing the same | |
| CN105961886A (en) | Feed additive used for broiler chickens and application thereof | |
| KR20180118520A (en) | PREPARED MARE MILK AND FORMULAR POEDER FOR STRENGTHENING MUSCALES OF PATIENTS WITH TREATMENT OF PARTICULAR PROBLEMS IN MYOPATHIES(PRM) CONTAINING MARE MILK HYDROLYZES WHEY PROTEIN(WPH) POWDER AND β-CASEIN | |
| CN111587923A (en) | An infant formula containing sialic acid and its preparation method | |
| CN104798891A (en) | Salting-out and adsorption processing method for low-purine soybean milk | |
| CN104431626A (en) | Compound pig meat conditioning agent and application thereof | |
| Mazumder et al. | A review on nutrient quality of soymilk powder for malnourished population | |
| CN103609701A (en) | Yoghourt suitable for patients with fatty liver to drink and processing process | |
| CN112205557A (en) | Hypolipidemic solid food beverage and preparation method thereof | |
| CN116636613A (en) | Formula food with full nutrition and special medical application as well as preparation method and application thereof | |
| CN105580983A (en) | Production method of low-cholesterol-content EPA-enriched eggs | |
| CN104782769A (en) | High-nutritive peanut milk production method | |
| JPH0753391A (en) | Composition for treating iron-deficiency anemia | |
| KR102650031B1 (en) | Composition for improving companion animal heart function and functional food containing the same | |
| CN105166901B (en) | A kind of dialysis patient alimentation composition | |
| CN104381933A (en) | Pickled cucumbers with special flavor | |
| CN104982768B (en) | A kind of jelly and preparation method thereof of suitable nephropathy patient's energy supplement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |